Aptose Biosciences Inc. (TSX: APS)

Author: Aptose Biosciences Inc.

Podcast with news and updates from Aptose Biosciences (NASDAQ: APTO, TSX: APS), a science-driven biotechnology company advancing first-in-class agents to treat life-threatening cancers, such as acute myeloid leukemia (AML), high-risk myelodysplastic syndromes (MDS) and other hematologic malignancies. Based on insights into the genetic and epigenetic profiles of certain cancers and patient populations, Aptose is building a pipeline of novel oncology therapies directed at dysregulated processes and signaling pathways.
Be a guest on this podcast

Language: en-us

Genres: Business, Investing

Contact email: Get it

Feed URL: Get it

iTunes ID: Get it

Get all podcast data